IMMUCELL CORP /DE/
ICCC · In Vitro & In Vivo Diagnostic Substances · 9.0M shares · +3%/yr ↑ dilution · EDGAR filings ↗
Reference price $9.49 · est. market cap ~$86M — last insider purchase, 2026-06-18 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
C56Small animal-health (dairy) products maker near breakeven with decent liquidity.
Strengths
- Operating-profitable, positive FCF — operating margin 6% (84th), FCF $1M (90th)
- Decent liquidity — current ratio 4.3 (73rd)
Risks
- Net loss — net margin -4%, net income -52%
- Small scale — per 10-K
- Product-approval/manufacturing risk — per 10-K
Notable findings
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
41.4%
Operating margin
6.0%
Net margin
-3.8%
Return on equity
-3.8%
Return on assets
-2.4%
ROIC
3.8%
Revenue growth (QoQ)
35.8%
Debt / equity
0.3×
Net debt / EBITDA
0.8×
Current ratio
4.3×
Free cash flow
$1M
EBITDA
$4M
Tangible book value
$27M
Cash & investments
$4M
Stock comp / revenue
1.1%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-18 | te Boekhorst Paul Francis Olivier | Buy | 8.0K | $9.49 |
| 2026-03-20 | BRIGHAM MICHAEL F | Tax withheld | 24K | $6.07 |
| 2026-03-20 | BRIGHAM MICHAEL F | Option exercise | 25K | $5.84 |
| 2025-12-04 | te Boekhorst Paul Francis Olivier | Buy | 2.4K | $5.50 |
| 2025-12-03 | te Boekhorst Paul Francis Olivier | Buy | 2.6K | $5.00 |
| 2025-12-03 | te Boekhorst Paul Francis Olivier | Buy | 3.6K | $5.04 |
| 2025-12-03 | te Boekhorst Paul Francis Olivier | Buy | 3.5K | $5.04 |
| 2025-12-02 | te Boekhorst Paul Francis Olivier | Buy | 3.7K | $4.87 |
| 2025-11-25 | Tomsche David Scott | Buy | 1.6K | $4.76 |
| 2025-11-25 | Tomsche David Scott | Buy | 1.6K | $4.76 |
| 2025-06-12 | Gathagan Bryan K. | Buy | 1.0K | $6.32 |
| 2025-06-11 | Basse Gloria F | Option exercise | 3.5K | $4.81 |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (0)
Suppliers (1)
- Maine Community Bank
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-17 | Shareholder voteExhibits | filing ↗ |
| 2026-06-10 | Reg FDExhibits | filing ↗ |
| 2026-05-14 | ResultsExhibits | filing ↗ |
| 2026-05-08 | Material agreement | filing ↗ |
| 2026-04-14 | Exec/director changeOtherExhibits | filing ↗ |
| 2026-04-08 | ResultsExhibits | filing ↗ |
| 2026-03-18 | Exec/director changeExhibits | filing ↗ |
| 2026-03-04 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-17 | 2026-06-11 | 0001437749-26-020926 ↗ |
| 8-K | 2026-06-10 | 2026-06-04 | 0001437749-26-020154 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001437749-26-017049 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001437749-26-017045 ↗ |
| 10-K/A | 2026-05-13 | 2025-12-31 | 0001437749-26-016719 ↗ |
| 8-K | 2026-05-08 | 2026-05-08 | 0001437749-26-015945 ↗ |
| 8-K | 2026-04-14 | 2026-04-07 | 0001437749-26-012182 ↗ |
| 8-K | 2026-04-08 | 2026-04-08 | 0001437749-26-011757 ↗ |
| 10-K | 2026-03-30 | 2025-12-31 | 0001437749-26-010339 ↗ |
| 8-K | 2026-03-18 | 2026-03-12 | 0001437749-26-008842 ↗ |
| 8-K | 2026-03-04 | 2026-03-04 | 0001437749-26-006912 ↗ |
| 8-K | 2026-02-09 | 2026-02-09 | 0001437749-26-003514 ↗ |